Trials / Completed
CompletedNCT05305391
Low-grade Inflammation and Gut Symptoms From A2 and Hydrolyses A1 Milk
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- University of Turku · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to reveal how different forms of milk casein, lactose and moderate breakdown of proteins affect the symptoms that may arise from milk and markers of inflammation in volunteers receiving symptoms from milk. Research hypotheses are: 1) Protein hydrolyzed milk is as tolerated or better tolerated than A2 milk, and 2) Lactose is the main causative agent of stomach symptoms in milk-sensitive individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dietary intervention | The arising gastrointestinal symptoms and inflammation markers from consumption of milk + lactase capsule / placebo. |
Timeline
- Start date
- 2022-05-18
- Primary completion
- 2023-03-03
- Completion
- 2023-03-03
- First posted
- 2022-03-31
- Last updated
- 2023-03-21
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT05305391. Inclusion in this directory is not an endorsement.